TOPAZ-1: Durvalumab Plus Gemcitabine and Cisplatin Could Become New First-Line S
- This topic has 1 reply, 1 voice, and was last updated 2 years, 10 months ago by
.
Viewing 2 posts - 1 through 2 (of 2 total)
-
Posts
-
TOPAZ-1: Durvalumab Plus Gemcitabine and Cisplatin Could Become New First-Line Standard of Care for Advanced Biliary Tract Cancer
https://dailynews.ascopubs.org/do/10.1200/ADN.22.200807/full/
Thanks to American Society of Clinical Oncology for this piece.
Gavin
Viewing 2 posts - 1 through 2 (of 2 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.